Literature DB >> 7121666

Glomerulotubular balance and functional compensation in nephrectomized children.

J Simon, I Zamora, S Mendizabal, V Castel, A Lurbe.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 7121666     DOI： 10.1159/000182647

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  6 in total

1.  Renal growth in patients nephrectomized for Wilms tumour as compared to renal agenesis.

Authors:  E Dinkel; J Britscho; M Dittrich; H Schulte-Wissermann; M Ertel
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

2.  Renal function following unilateral nephrectomy for neuroblastoma and Wilms' tumour.

Authors:  M Schell; P Cochat; A Hadj-Aïssa; E Bouffet; L Dubourg; M Brunat-Mentigny
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

Review 3.  Renal agenesis and unilateral nephrectomy: what are the risks of living with a single kidney?

Authors:  Shivaram Hegde; Malcolm G Coulthard
Journal:  Pediatr Nephrol       Date:  2008-07-09       Impact factor: 3.714

4.  Kidney function in adults born with unilateral renal agenesis or nephrectomized in childhood.

Authors:  I Wikstad; G Celsi; L Larsson; P Herin; A Aperia
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

5.  Increased risk for kidney sequelae surrogates in survivors of Wilms tumor.

Authors:  Emrullah Arslan; Seha Saygili; Tülin Tiraje Celkan; Sebuh Kurugoglu; Mehmet Elicevik; Abdulhamit Enes Camcioglu; Dildar Konukoglu; Hilmi Apak; Salim Caliskan; Lale Sever; Nur Canpolat
Journal:  Pediatr Nephrol       Date:  2022-02-03       Impact factor: 3.651

6.  Retrospective study to identify risk factors for chronic kidney disease in children with congenital solitary functioning kidney detected by neonatal renal ultrasound screening.

Authors:  Adela Urisarri; Marta Gil; Natalia Mandiá; Luís Aldamiz-Echevarría; Roca Iria; Domingo González-Lamuño; María-Luz Couce
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.